The AGIO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGIO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AGIO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AGIO Detailed Price Forecast - CNN Money||View AGIO Detailed Summary - Google Finance|
|View AGIO Detailed Summary - Yahoo! Finance||View AGIO Stock Research & Analysis - Zacks.com|
|View AGIO Trends & Analysis - Trade-Ideas||View AGIO Major Holders - Barrons|
|View AGIO Call Transcripts - NASDAQ||View AGIO Breaking News & Analysis - Seeking Alpha|
|View AGIO Annual Report - CompanySpotlight.com||View AGIO OTC Short Report - OTCShortReport.com|
|View AGIO Fundamentals - TradeKing||View AGIO SEC Filings - Bar Chart|
|View Historical Prices for AGIO - The WSJ||View Performance/Total Return for AGIO - Morningstar|
|View the Analyst Estimates for AGIO - MarketWatch||View the Earnings History for AGIO - CNBC|
|View the AGIO Earnings - StockMarketWatch||View AGIO Buy or Sell Recommendations - MacroAxis|
|View the AGIO Bullish Patterns - American Bulls||View AGIO Short Pain Metrics - ShortPainBot.com|
|View AGIO Stock Mentions - StockTwits||View AGIO Stock Mentions - PennyStockTweets|
|View AGIO Stock Mentions - Twitter||View AGIO Investment Forum News - Investor Hub|
|View AGIO Stock Mentions - Yahoo! Message Board||View AGIO Stock Mentions - Seeking Alpha|
|View Insider Transactions for AGIO - SECform4.com||View Insider Transactions for AGIO - Insider Cow|
|View AGIO Major Holdings Summary - CNBC||View Insider Disclosure for AGIO - OTC Markets|
|View Insider Transactions for AGIO - Yahoo! Finance||View Institutional Holdings for AGIO - NASDAQ|
|View AGIO Stock Insight & Charts - FinViz.com||View AGIO Investment Charts - StockCharts.com|
|View AGIO Stock Overview & Charts - BarChart||View AGIO User Generated Charts - Trading View|
Agios Pharmaceuticals, Inc. (AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the initiation of the Phase 3 ACTIVATE trial evaluating AG-348, a first-in-class, selective, small molecule activator of the pyruvate kinase-R (PKR) enzyme. ACTIVATE is a randomized, placebo-controlled trial that will enroll approximately 80 adults with pyruvate kinase (PK) deficiency who do not receive regular blood transfusions. “AG-348 is the first potential treatment for PK deficiency that targets the underlying cause of a patient’s anemia and has demonstrated robust and sustained hemoglobin increases in adults with this disease who are not regularly transfused,” said Chris Bowden, M.D., chief medical officer of Agios.
Agios Pharmaceuticals, Inc.Stock Is an Analyst Darling for Good Reason
Posted on Tuesday June 05, 2018
As Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) closes at new highs, analysts are gushing over the company’s prospects. What is it about Agios stock that has the experts bullish on the company? Markets speculated that Celgene Corporation (NASDAQ:CELG) would buy Agios or Jounce Therapeutics, Inc. (NASDAQ:JNCE) back in April.
New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients
Posted on Monday June 04, 2018
-Safety Profile of Combination Therapies Consistent with Single Agent IDHm Inhibitors and Azacitidine-. -ORR of 78%, CR Rate of 44% and CR/CRi/CRp Rate of 65% in the Ivosidenib Arm; Molecular Clearance ...
Agios Pharmaceuticals (AGIO) Up 13.4% Since Earnings Report: Can It Continue?
Posted on Monday June 04, 2018
Agios Pharmaceuticals (AGIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.